Ajit Singh – Chairman, ACG
Solid dosage forms like capsules and tablets make up over 70 percent of all medicines prescribed globally. In the view of Ajit Singh, chairman of Indian solid dosage form pioneer…
Address: Dalamal House, Nariman Point,Mumbai – 400 021, India. ,India
Tel: +91-22-3008 9444 / 45
Web: http://www.acg-world.com/
ACG Worldwide has been serving the global pharmaceutical industry for over five decades and is the second largest manufacturer of empty hard capsules in the world. The group comprises of 13 companies, including subsidiaries in China, USA, Indonesia, Brazil and Europe.
ACG Worldwide has an active presence in over 100 countries with its products and services, employing approximately 3,200 members that strive to provide world-class technology across multiple domains. We offer a complete range of solutions beginning with empty capsules; granulation and coating; capsule filling; tabletting machinery; packaging films; blister packing; carton packing; tablet tooling; camera inspection systems and end-of-line solutions. With over 20,000 machine installations worldwide, it speaks lengths of the high quality standards we follow and maintain at ACG along with complying to major international quality certifications or legislations.
ACG Worldwide is committed to delivering a high level of solid dosage form to the global pharma industry. Our research teams endeavor to develop innovative technology in order to continually give our customers the benefit of a cost competitive edge plus world-class technology. ‘SciTech Centre’, the group’s 50,000 sq. ft. R & D center located in the heart of Mumbai, is a government-recognized research institution. In the last 25 years, it has witnessed breakthroughs in dosage form development including pharmaceutical engineering and delivery systems.
Manufacturing Solutions
ACG Worldwide offers end-to-end solutions in solid dosage for the pharmaceutical, OTC and dietary supplements industry…
Packaging Solutions
Our packaging solutions include high barrier packaging films from ACG Pharmapack, blister-packing & cartoning machines from ACG Pampac and Camera inspection systems from ACG Inspection.
R & D Solutions
ACG Worldwide is committed to its customer’s from the R & D stage. It manufactures Clinicaps – capsules for clinical trials, a lab model of automatic capsule filling machine, packaging films and tablet tooling sets for R & D start-ups.
Industry
ACG Worldwide develops and helps its customers with varied solutions to meet every marketing need. Experienced personnels from ACG, work closely with their customer right from initial stage, that is understanding the requirements, to addressing the needs by offering an effective solution.
Solid dosage forms like capsules and tablets make up over 70 percent of all medicines prescribed globally. In the view of Ajit Singh, chairman of Indian solid dosage form pioneer…
For decades now, ACG has been building up its reputation in the global pharma space. The Indian Pharma industry, at the same time, increasingly is catching up with the Western…
For decades now, ACG has been building up its reputation in the global pharma space. The Indian Pharma industry, at the same time, increasingly is catching up with the Western…
As managing director of India’s fifth largest pharmaceutical company, Zydus Cadila’s Sharvil Patel shares his insights on his impressive internationalization strategy with a special focus on the US where Zydus…
A successful commercial leader, Annaswamy Vaidheesh, president of OPPI, VP South Asia and managing director at GSK India, talks about the tremendous work that the local affiliate is doing in…
A strong supporter of public-private partnerships, MSD’s managing director in India, Vivek Kamath, explains how the company’s collaborative approach is the key to enhancing their reputation, improving patient outcomes and…
Ashok Battacharya, executive director of the Indian affiliate of Takeda Pharmaceuticals, with 38 years experience in global Ppharmaceutical MNCs, discusses the top-notch reputation that Takeda has among physicians and patients…
Think global, act local! This is the Novartis business approach in India. A great believer in stakeholder collaboration, Jawed Zia, country president of Novartis India, explains how co-marketing deals with…
Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven by some key global biologic drugs facing loss of exclusivity in…
Alexandre Williams, founder and managing director of Athena, an international company with an Indian manufacturing basis specialized in life cycle products, provides insights into some key trends shaping India’s pharmaceutical…
As the founder and chairman of Alves Group, a key Indian player in medical devices with an extensive portfolio, Randolph Alves shares the challenges India needs to overcome to remain…
Dharmesh Shah, managing director of BDR Pharmaceuticals, a company with a strong expertise in oncology, intensive care, and other therapeutic areas, provides us with an insightful overview of the main…
For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India still stands as a land of opportunity for a variety of reasons. Novartis India…
Umang Vohra, managing director and global CEO of Indian pharma giant Cipla, discusses the company’s ambition to grow in both the domestic and emerging markets as well as the opportunities…
Nikhil Masurkar, executive director of Entod Pharmaceuticals, talks about the company’s ambition to invest in stem cell research and become market leaders in the field of ophthalmology in ten years’…
See our Cookie Privacy Policy Here
